Affordable GLP-1 weight loss medication starting at $297/mo. Licensed providers, free shipping.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Mounjaro Cost is already seeing results
Mounjaro Cost: Weight Method offers GLP-1 treatment starting at $297/month, significantly less than the brand-name retail price of $1,000-$1,500/month. Semaglutide from $297/month and tirzepatide from $349/month. Includes virtual medical consultation and free direct shipping.
Key Fact
Mounjaro (tirzepatide) costs $1,000-$1,100/month at retail pharmacies. Weight Method offers the same active ingredient at $349/month for weight management — approximately 65-68% less than retail, with no diagnostic restrictions.
Source: Weight Method pricing, February 2026
Mounjaro's pricing follows the standard specialty pharmaceutical model, with Eli Lilly setting a list price of approximately $1,060 per month. Actual pharmacy prices vary by location and dose — the starting dose (2.5mg) and maintenance doses (10mg-15mg) are priced similarly, though some pharmacies charge more for higher-dose pens. Cash-pay discount tools like GoodRx may bring prices down to $800-$950, but availability of these discounts is inconsistent. Insurance coverage for Mounjaro is strongest when prescribed for type 2 diabetes, where it may sit on a preferred brand tier with copays of $50-$150 per month. For weight loss, coverage is almost nonexistent since Mounjaro's FDA label is diabetes-specific. Some physicians write Mounjaro prescriptions with a diabetes diagnosis code to improve coverage odds, but this practice creates compliance risks and doesn't guarantee approval. Weight Method's $349/month tirzepatide pricing is transparent and unconditional. Every dose level costs the same. There is no insurance to navigate, no diagnostic coding to worry about, and no risk of claim denial. The price includes your medication, provider consultations, dose management, and home delivery.
Annual savings with Weight Method versus retail Mounjaro pricing: $7,812 to $9,012 per year. For patients currently paying $1,000+/month for Mounjaro at a pharmacy, switching to Weight Method immediately frees up $650+ per month — money that can be redirected toward other health investments or financial priorities. The cost efficiency of tirzepatide becomes even more compelling when measured against outcomes. At $349/month through Weight Method, tirzepatide delivers 20-25% average body weight loss. On a per-percentage-point basis, this represents one of the most cost-effective medical interventions for obesity available today. Compared to bariatric surgery ($15,000-$30,000 upfront), a year of tirzepatide at Weight Method ($4,188) achieves comparable weight loss percentages at a fraction of the cost. Patients who have been avoiding tirzepatide due to the retail price should know that Weight Method's pricing makes this premium medication accessible. The $349/month rate is less than what many patients pay in combined gym memberships, diet programs, and supplements — all of which have far lower evidence bases for sustained weight loss.
Answer a few quick questions to see if you qualify for GLP-1 medication.
Check EligibilityClinically proven GLP-1 medications at transparent prices

Same active ingredient as Ozempic® & Wegovy®. Proven to reduce body weight by up to 15%.

Same active ingredient as Mounjaro® & Zepbound®. Dual-action GLP-1/GIP for enhanced results.
We offer the most affordable GLP-1 treatments. Starting at $297/month.
See PricingFree consultation. No commitment.